Association between apolipoprotein E genotype, serum lipids, and colorectal cancer in Brazilian individuals

Brazilian Journal of Medical and Biological Research

Volumn 42, Issue 5, 2009, Pages 397-403

  Souza, Doroteia R S ^a   Nakazone, M A ^a   Pinhel, M A S ^a   Alvares, R M ^a   Monaco, A C ^a   Pinheiro, A ^a   Barros, C F D C ^a   Cury, P M ^a   Cunrath, G S ^a   Netinho, J G ^a  

^a FACULDADE DE MEDICINA DE SÃO JOSÉ DO RIO PRETO   (Brazil)

Author keywords

Apolipoprotein E; Colorectal cancer; Lipid profile; Polymorphisms

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ALLELE; ARTICLE; BODY MASS; BRAZIL; CHOLESTEROL BLOOD LEVEL; COLORECTAL CANCER; CONTROLLED STUDY; DNA POLYMORPHISM; EATING HABIT; FEMALE; GENETIC VARIABILITY; GENOTYPE; HUMAN; HYPERTENSION; LIPID BLOOD LEVEL; LIPID METABOLISM; LIPOGENESIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; OBESITY; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 68249136925     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2009000500001     Document Type: Article

References (33)

1. Rao CV, Hirose Y, Indranie C, Reddy BS. Modulation of experimental colon tumorigenesis by types and amounts of dietary fatty acids. Cancer Res 2001; 61: 1927-1933.
2. Rabelo R, Foulkes W, Gordon PH, Wong N, Yuan ZQ, MacNamara E, et al. Role of molecular diagnostic testing in familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer families. Dis Colon Rectum 2001; 44: 437-446.
3. Aaltonen LA, Peltomaki P, Leach FS, Sistonen P, Pylkkanen L, Mecklin JP, et al. Clues to the pathogenesis of familial colorectal cancer. Science 1993; 260: 812-816.
4. Tornberg SA, Holm LE, Carstensen JM, Eklund GA. Risks of cancer of the colon and rectum in relation to serum cholesterol and beta-lipoprotein. N Engl J Med 1986; 315: 1629-1633.
5. Chung YW, Han DS, Park YK, Son BK, Paik CH, Lee HL, et al. Association of obesity, serum glucose and lipids with the risk of advanced colorectal adenoma and cancer: a case-control study in Korea. Dig Liver Dis 2006; 38: 668-672.
6. Souza DR, Nakachima L, Biagioni RB, Nakazone MA, Pinhel MA, Trindade DM, et al. Relevance of apolipoprotein E4 for the lipid profile of Brazilian patients with coronary artery disease. Braz J Med Biol Res 2007; 40: 189-197.
7. Shinomiya S, Sasaki J, Kiyohara C, Tsuji E, Inoue H, Marugame T, et al. Apolipoprotein E genotype, serum lipids, and colorectal adenomas in Japanese men. Cancer Lett 2001; 164: 33-40.
8. Watson MA, Gay L, Stebbings WS, Speakman CT, Bingham SA, Loktionov A. Apolipoprotein E gene polymorphism and colorectal cancer: gender-specific modulation of risk and prognosis. Clin Sci 2003; 104: 537-545.
9. Slattery ML, Sweeney C, Murtaugh M, Ma KN, Potter JD, Levin TR, et al. Associations between apoE genotype and colon and rectal cancer. Carcinogenesis 2005; 26: 1422-1429.
10. Kervinen K, Sodervik H, Makela J, Lehtola J, Niemi M, Kairaluoma MI, et al. Is the development of adenoma and carcinoma in proximal colon related to apolipoprotein E phenotype? Gastroenterology 1996; 110: 1785-1790.
11. Gustincich S, Manfioletti G, Del Sal G, Schneider C, Carninci P. A fast method for high-quality genomic DNA extraction from whole human blood. Biotechniques 1991; 11: 298-300, 302.
12. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 1990; 31: 545-548.
13. Bucolo G, David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem 1973; 19: 476-482.
14. Allain CC, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem 1974; 20: 470-475.
15. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
16. Sposito AC, Caramelli B, Fonseca FA, Bertolami MC, Afiune NA, Souza AD, et al. IV Brazilian Guideline for Dyslipidemia and Atherosclerosis prevention: Department of Atherosclerosis of Brazilian Society of Cardiology. Arq Bras Cardiol 2007; 88 (Suppl 1): 2-19.
17. IV Brazilian guidelines in arterial hypertension. Arq Bras Cardiol 2004; 82 (Suppl 4): 7-22.
18. World Health Organization (WHO). Physical status: the use and interpretation of anthropometry. Geneve: WHO, Technical Report Series, 841; 1995.
19. Xu J, Turner A, Little J, Bleecker ER, Meyers DA. Positive results in association studies are associated with departure from Hardy-Weinberg equilibrium: hint for genotyping error? Hum Genet 2002; 111: 573-574. 20 Wittke-Thompson JK, Pluzhnikov A, Cox NJ. Rational inferences about departures from Hardy-Weinberg equilibrium. Am J Hum Genet 2005; 76: 967-986.
20. Pinhel MA, Nakazone MA, Cacao JC, Piteri RC, Dantas RT, Godoy MF, et al. Glutathione S-transferase variants increase susceptibility for late-onset Alzheimer's disease: association study and relationship with apolipoprotein E epsilon4 allele. Clin Chem Lab Med 2008; 46: 439-445.
21. Forones NM, Falcao JB, Mattos D, Barone B. Cholesterolemia in colorectal cancer. Hepatogastroenterology 1998; 45: 1531-1534.
22. Kreger BE, Anderson KM, Schatzkin A, Splansky GL. Serum cholesterol level, body mass index, and the risk of colon cancer. The Framingham Study. Cancer 1992; 70: 1038-1043.
23. Schubert CM, Rogers NL, Remsberg KE, Sun SS, Chumlea WC, Demerath EW, et al. Lipids, lipoproteins, lifestyle, adiposity and fat-free mass during middle age: the Fels Longitudinal Study. Int J Obes 2006; 30: 251-260.
24. Lundqvist E, Kaprio J, Verkasalo PK, Pukkala E, Koskenvuo M, Soderberg KC, et al. Co-twin control and cohort analyses of body mass index and height in relation to breast, prostate, ovarian, corpus uteri, colon and rectal cancer among Swedish and Finnish twins. Int J Cancer 2007; 121: 810-818.
25. Strohle A, Maike W, Hahn A. Nutrition and colorectal cancer. Med Monatsschr Pharm 2007; 30: 25-32.
26. Schoen RE, Tangen CM, Kuller LH, Burke GL, Cushman M, Tracy RP, et al. Increased blood glucose and insulin, body size, and incident colorectal cancer. J Natl Cancer Inst 1999; 91: 1147-1154.
27. Chlebowski RT, Wactawski-Wende J, Ritenbaugh C, Hubbell FA, Ascensao J, Rodabough RJ, et al. Estrogen plus progestin and colorectal cancer in postmenopausal women. N Engl J Med 2004; 350: 991-1004.
28. Schiffman MH, Felton JS. Re: "Fried foods and the risk of colon cancer". Am J Epidemiol 1990; 131: 376-378. 30. Casimiro C. Etiopathogenic factors in colorectal cancer. Genetic and clinical features (first of 2 parts). Nutr Hosp 2002; 17: 63-71.
29. Fujimori S, Kishida T, Mitsui K, Yonezawa M, Nagata K, Shibata Y, et al. Influence of alcohol consumption on the association between serum lipids and colorectal adenomas. Scand J Gastroenterol 2002; 37: 1309-1312.
30. Bowers K, Albanes D, Limburg P, Pietinen P, Taylor PR, Virtamo J, et al. A prospective study of anthropometric and clinical measurements associated with insulin resistance syndrome and colorectal cancer in male smokers. Am J Epidemiol 2006; 164: 652-664.
31. Kune GA, Kune S, Watson LF. Colorectal cancer risk, chronic illnesses, operations, and medications: case control results from the Melbourne Colorectal Cancer Study. Cancer Res 1988; 48: 4399-4404.
32. Negri E, Bosetti C, La Vecchia C, Levi F, Tomei F, Franceschi S. Allergy and other selected diseases and risk of colorectal cancer. Eur J Cancer 1999; 35: 1838-1841.
33. Larsson SC, Orsini N, Wolk A. Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst 2005; 97: 1679-1687.